Libris Innovations, the for-profit subsidiary of the Indiana Biosciences Research Institute (IBRI), has appointed Ramani ...

Ardena has completed the process of divesting its active pharmaceutical ingredient (API) site in Södertälje, Sweden, to Nanologica AB.

Merz Therapeutics has appointed Dan Staner as President, Region Europe, effective February 1, 2026. In this role, Staner will ...

Eli Lilly and Company has chosen the Lehigh Valley in Pennsylvania for its next manufacturing site in a $3.5 billion ...

AstraZeneca has announced a $15 billion investment in China through 2030 to expand medicines manufacturing and R&D.

WuXi Biologics and Sinorda Biomedicine have jointly announced a strategic collaboration for the development and manufacturing ...

Extractables and Leachables (E&L) issues are quietly derailing nearly one in five drug applications, as shown by hundreds of ...

IQVIA and its Data-as-a-Service (DaaS+) technology have been chosen by Boehringer Ingelheim in a new, strategic long-term ...

Potency assays are central to proving a therapy activity and safety, yet for advanced therapies like cell and gene therapies ...

Siegfried, a global CDMO for the pharmaceutical industry, has signed binding agreements with an affiliate of SK Capital ...

Veeva Systems has announced Veeva eSource, a new Veeva SiteVault application designed to streamline the flow of clinical ...

Satellos Bioscience Inc., a clinical-stage biotechnology company, has appointed Antoinette Paone as Chief Development Officer ...